RxDoctor Payments Data

Joseph Moriarity, OD

Optometrist · Greenville, OHNPI 1598322844

Payments from drug & device makers

$853in general payments, 2019–2025

Across 39 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$332
  • Bausch & Lomb Americas Inc.$103
  • Alcon$94
  • Aerie Pharmaceuticals, Inc.$51
  • Novartis$40
  • Glaukos Corporation$39
  • plus $194 from 10 others

What the payments were for

  • Food & beverage$853100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$853 in reported general payments places this provider in the 55th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio

Medicare billing

Part B allowed, 2024
$172,447
Medicare patients
856
Services billed
2,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine35$34,434
LumiganBimatoprost22$9,715
RhopressaNetarsudil Mesylate16$5,272
Prednisolone Acetate229$5,164
Latanoprost207$2,183
Brimonidine Tartrate101$1,681
Fluorometholone23$1,429
MoxifloxacinMoxifloxacin Hcl24$723
Dorzolamide Hcl47$717
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat39$619
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha41$404
Ketorolac Tromethamine17$321
Timolol Maleate41$277
Ofloxacin21$253
ErythromycinErythromycin Base11$132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan$332$44,15057 claims
Aerie Pharmaceuticals, Inc.Rhopressa$51$5,27216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,995 optometrist providers in Ohio.

Other optometrist in Greenville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →